Hirudoid forte and placebo were applied for 10 days.
特强喜疗妥制剂和安慰剂分别应用了10天。
Hirudoid and Hirudoid forte have excellent skin tolerability.
喜疗妥和喜疗妥特强软膏有极佳的皮肤耐受性。
Hirudoid forte inhibit enzymes that cause tissue degeneration.
特强喜疗妥乳膏能抑制导致组织分解代谢的酶。
No local reactions as result of the treatment with Hirudoid were observed.
未观察到因应用喜疗妥治疗而引起的局部反应。
Thus, Hirudoid showed to have an equivalent efficacy and safety to the approved preparation.
因此，喜疗妥的有效性和安全性与这一被认可的制剂相同。
Walther et al. documented the antithrombotic efficacy of Hirudoid in a comparative animal study.
在另一相当的动物研究中，Walther等人同样论证了喜疗妥的抗血栓作用。
The excellent tolerability of Hirudoid and Hirudoid forte is therefore of particular importance.
喜疗妥和特强喜疗妥由于其极好的耐受性而特别重要。
Hirudoid and Hirudoicl forte have been used over decades worldwide in an extensive number of patients.
喜疗妥和特强喜疗妥软膏已经数十年在全世界范围广泛应用于大量患者。
Based on these results, hirudoid ointment is considered to be a useful drug for the treatment of senile xerosis.
基于这些研究，喜疗妥软膏被认为是治疗老年性干燥症的有效药物。
There was a significant faster dissolution of haematomas under the treatment with Hirudoid in comparison to placebo.
血肿的分解，喜疗妥组要显著快于安慰剂组。
One ear was treated with Hirudoid cream, while the other ear was either left untreated or treated with the cream base only.
一只耳朵用喜疗妥软膏治疗，而另一只耳朵则不治疗或只用软膏基质治疗。
Levai reported on 243 patients who were treated with Hirudoid gel for different venous disorders of the lower extremities.
Levai报道了用喜疗妥凝胶治疗243位末梢静脉疾病患者。
The more rapid regression of thrombosis under treatment with Hirudoid was associated with an accelerated relief of symptoms.
用喜疗妥治疗后，血栓衰退更迅速，这是与症状的加速改善相对应的。
Therapy with Hirudoid and Hirudoid forte is without systemic adverse reactions and without influence on systemic coagulation.
用喜疗妥和特强喜疗妥治疗，没有全身副作用，不影响凝血系统。
The investigating physicians assessed the skin tolerability of Hirudoid and Hirudoid forte as good or very good in 97,3 % of all cases.
调查医师对喜疗妥或特强喜疗妥的皮肤耐受性评价为好或非常好的病例百分比为97.3％。
Hirudoid has been proven to significantly improve the metabolic situation in the early pressure areas when compared to placebo treatment.
经论证，对于早期受压区域代谢的改善，喜疗妥组显著优于安慰剂组。
After topical application of Hirudoid and Hirudoid forte plasma levels of MPS are Iow and no influence on blood coagulation can be determined.
外用喜疗妥和特强喜疗妥软膏后，MPS血浆水平很低并且不影响凝血系统。
The results show a significantly faster absorption of haematomas treated with Hirudoid cream compared with placebo-treated and totally untreated controls.
实验结果显示，血肿的吸收喜疗妥组比安慰剂组和完全不治疗组要快得多。
Therefore a urea - containing ointment, established and approved in the treatment of senile xerosis was chosen as a comparator to evaluate the efficacy of hirudoid.
因此，尿素软膏，作为被认可的用于老年性干燥症的常用制剂，被选为对照药物用于评估喜疗妥的疗效。
After the administration of Hirudoid thrombi induced in the ear vein of the mouse were dissolved within a few days and the affected vascular systems were rechannelled.
涂抹喜疗妥后，小鼠耳静脉的人造栓塞在很短的几天内很快分解了。
Within the one week therapy with Hirudoid the inflammatory signs in all patients had either completely subsided or had improved to such an extent that a complete healing was achieved.
在用喜疗妥治疗的一周期间，所用患者的炎症均显著减轻或痊愈了。
In an additional placebo controlled double-blind study the efficacy of Hirudoid cream was assessed in treating superficial thrombophlebitis developing after continuous infusion (Metha et al.).
另外一项安慰剂对照的双盲研究，评估了喜疗妥软膏治疗由于持续注射而引起的浅表血栓性静脉炎的疗效(Metha等人)。
Compression and the use of topical preparations represent the basic therapy for many venous disorders. The excellent tolerability of Hirudoid and Hirudoid forte is therefore of particular importance.
局部压迫和外用制剂是许多静脉疾病的基础治疗。喜疗妥和特强喜疗妥由于其极好的耐受性而特别重要。
Compression and the use of topical preparations represent the basic therapy for many venous disorders. The excellent tolerability of Hirudoid and Hirudoid forte is therefore of particular importance.
局部压迫和外用制剂是许多静脉疾病的基础治疗。喜疗妥和特强喜疗妥由于其极好的耐受性而特别重要。
应用推荐